Episode Details:
Our Guest: Brian Culley, CEO at Lineage Cell Therapeutics
What you’ll get out of this episode:
- Culley’s background and how he got to Lineage
- Lineage’s technology platform and what it means to be an allogeneic, off-the-shelf, cell therapy company
- The competitive advantages to this approach – specifically, manufacturing, and patient access
- Lineage’s current clinical programs in development and the latest advancements
- Milestones for Lineage
Watch –
Listen
WORD FROM OUR SPONSORS:
Our sponsors for this episode are Sage Growth Partners & FlipMD
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners
FlipMD is an open, competitive marketplace of physicians only offering their consulting services to a wide range of client industries. The ultimate goal of flipMD is to be the best source of physician talent for any industry. The platform is very simple to use, you post a job for free with the specific scope of work and your budget. After the job posting, our physicians respond directly to you with their best offer for the work. Once you accept an offer, you fund the project. Once you receive satisfactory work, you accept and the funds are released to your expert physician consultant. For more information, please go to https://flip-md.com/ & follow FlipMD on social media – @flipmd
To learn more about Lineage Cell Therapeutics please use the links below:
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – Facebook – LinkedIn – Twitter – YouTube – Newsletter
